FocalTherics share price logo

FocalTherics

NASDAQ: FOCL

$4.20

+0.11

(+2.69%)

as on

FocalTherics Stock Performance

as on October 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.05
    $4.22
    downward going graph

    3.57%

    Downside

    0.48%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

FocalTherics share price movements today

Previous Close
$4.09
Open
$4.17
Volume
186.1K
Market Cap
$193.1M
Day's Low - High
$4.05 - $4.22

FocalTherics Historical Returns

1 Month Return
-1.45 %
3 Month Return
-24.75 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

FocalTherics Stock Fundamentals & Key Indicators

Check FocalTherics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$193.1M

EPS (TTM)

-1.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.93

Industry PE ratio

-13.06

PEG Ratio

0.06

EBITDA

-26.4M

Revenue (TTM)

69.1M

Profit Margin

45.98%

Return On Equity TTM

-289.98%

FocalTherics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of FocalTherics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$193.1MNA-3.9345.98%0.00%
StrongBuy$58.8B422.43%34.903.84%0.81%
StrongBuy$117.2B396.00%26.613.64%0.34%
Buy$65.1B142.23%25.253.71%0.70%
Buy$9.6B12.24%25.1430.31%0.00%

Analyst Recommendation on FocalTherics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for FocalTherics. Average target price of $10

FocalTherics Share Price Target

Get share price movements and forecasts by analysts on FocalTherics.

Current Price

$4.2

Analyzed by

1 Analysts

High

$10

0

Low

$10

FocalTherics target price $0, a slight upside of 0% compared to current price of $4.2. According to 1 analysts rating.

Indian Investors' Interest in FocalTherics Stock

Search interest for FocalTherics Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

FocalTherics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
21
16
17
21
14
18
16
21
17
13
Gross Profit
9
6
6
9
5
7
6
9
8
7
Operating Income
-3
-5
-6
-3
-6
-6
-5
-6
-7
-8
EBITDA
-5
-4
-6
0
-7
-5
-5
-6
-6
-8
Interest Expense
-
-
-
-
-
0
0
3
1
0
Depreciation
-
-
-
2
-
0
-
-
0
-
Income Before Tax
-5
-4
-6
-2
-7
-6
-5
-9
-8
-14
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-5
-4
-6
-2
-7
-6
-5
-9
-9
-14
Net Profit Margin
43.65%
42.83%
37.48%
44.78%
42.00%
42.52%
43.02%
42.58%
45.73%
55.58%

FocalTherics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
40
46
50
47
52
57
65
69
70
Gross Profit
16
19
23
20
21
25
26
28
30
Operating Income
-2
-2
1
0
-3
-5
-22
-22
-25
EBITDA
0
0
3
2
2
0
-20
-17
-25
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
1
1
2
2
2
1
2
2
3
Income Before Tax
0
0
1
-1
0
-2
-22
-20
-29
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
0
0
1
-1
0
-3
-22
-20
-29
Net Profit Margin
41.43%
43.17%
46.76%
44.11%
41.81%
43.90%
40.40%
41.42%
42.54%

FocalTherics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-4
-6
-2
-7
-6
-5
-9
-9
-14
Operating Cash Flow
-4
-4
-6
0
-5
-4
-3
-2
-2
-3
Investing Cash Flow
0
-1
0
-1
-1
-1
-1
-1
0
-1
Financing Cash Flow
0
0
-1
5
-1
0
-1
11
-1
11
Change in Cash
-2
-6
-41
30
-30
-5
-19
20
-5
-15

FocalTherics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
1
-1
0
-3
-22
-20
-29
Operating Cash Flow
-3
0
4
2
5
-3
-15
-14
-16
Investing Cash Flow
-2
-1
-1
-2
-1
-2
-4
-4
-5
Financing Cash Flow
3
1
0
3
23
22
0
5
8
Change in Cash
0
-1
1
6
23
13
-19
-17
-10

Global Institutional Holdings in FocalTherics

Check out the Institutions with significant holdings in FocalTherics.

Funds
Holdings
Robert Bruce
1.17%
Bruce Fund, Inc.
1.11%
Fidelity Concord Street Trust
0.06%

Insights on FocalTherics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, FOCL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, FOCL stock has moved up by 82.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Cardinal Health, Inc. has given 173.8% return, outperforming this stock by 211.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 21.86M → 13.18M (in $), with an average decrease of 22.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.11M → -14.46M (in $), with an average decrease of 58.7% per quarter

About FocalTherics

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
OrganisationFocalTherics
HeadquartersParc d’Activites la Poudrette-Lamartine, Vaulx-en-Velin, ARA, 69120, FR
IndustryMedical - Devices
CEORyan Rhodes

Key Management of FocalTherics

Name

Title

Mr. Carre Emmanuel

Chief Operating Officer

Mr. Sanket Shah J.D.

General Counsel & Corporate Secretary

Ms. Blandine Confort

Head of Legal Affairs & Investor Relations and Secretary

Mr. Frederic Pech

President of EDAP TMS France

Mr. Jean-Francois Bachelard

President & Chief Executive Officer of Edaptechnomed Co. Ltd.

Mr. Ryan Rhodes

CEO & Director

Mr. Kenneth Mobeck

Chief Financial Officer

Mr. Steven Annen

Executive Vice President of Marketing & Product Management

Mr. Francois Dietsch

Chief Accounting Officer

FAQs

What is FocalTherics share price today?

FocalTherics share price today is $4.20 as on at the close of the market. FocalTherics share today touched a day high of $4.22 and a low of $4.05.

What is the 52 week high and 52 week low for FocalTherics share?

FocalTherics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . FocalTherics stock price today i.e. is closed at $4.20,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is FocalTherics's market capitalisation today?

FocalTherics market capitalisation is $0.00T as on .

How to invest in FocalTherics Stock (FOCL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for FocalTherics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy FocalTherics Stock (FOCL) from India?

Indian investors can start investing in FocalTherics (FOCL) shares with as little as ₹94.91500091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.15 in FocalTherics stock (as per the Rupee-Dollar exchange rate as on ). Based on FocalTherics share’s latest price of $4.20 as on October 20, 2026 at 1:29 am IST, you will get 2.3810 shares of FocalTherics. Learn more about fractional shares .